PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home »

Psychiatric Times. Vol. 24 No. 4
Pages: 1  2  
Previous
 

The Religion of Benzodiazepines

By Cynthia M. A. Geppert, MD, PhD | April 1, 2007
Dr Geppert is chief of behavioral care consultation and medical director of the substance abuse residential rehabilitation treatment program at the New Mexico Veterans Affairs Health Care System in Albuquerque. She is also assistant professor in the department of psychiatry and associate director of religious studies at the University of New Mexico in Albuquerque.

Puritanism and hedonism
Contrary to its use in popular parlance, hedonism was an ethical theory that advocated not indulgence and excess but the good life worth living, of which pleasure was an important condition. Epicurus, one of the chief exponents of the theory, taught that humans should seek to attain a state of ataraxia, free from fear, trouble, pain, and anxiety—not unlike what contemporary clinicians endeavor to bring about through the use of anxiolytics.8 Puritanism is both a religious movement and a worldview; the latter can be traced back to ancient rivals of the Epicureans, the Stoics. Puritanism emphasized daily self-examination; hard work; and a demanding, austere moral code for individual, social, and economic life.9

Implications for prescribing
When these 2 fundamentally different and, I might venture, fundamental responses toward pain and peace in the human condition are applied to the prescribing of benzodiazepines, parallel sets of presuppositions and habits emerge. Clinicians who are on the conservative end of the prescribing spectrum weigh more heavily their own responsibility for causing psychomotor impairment and falls in the elderly and triggering or exacerbating abuse and dependence in those with an uncertain diathesis to addiction. This is in part a medical but also a moral, or in some frames of reference, a theological judgment, that anxiety, while not trivial, may be a lesser evil for which there are effective treatments—antidepressants and cognitive-behavioral therapy—with more benign side effects.10 Those on the more liberal end of the continuum of prescribing seem to place the locus of accountability more on patients—accepting their prima faciedescription of their anguish and their ability to maturely manage a controlled substance. While not discounting the real adverse possibilities of benzodiazepines, these physicians view the burden of worry, terror, or sleeplessness in anxious patients as far greater and more tangible.11

A series of fascinating studies done with general practitioners in Norway regarding their prescribing of benzodiazepines supports this somewhat simplistic schema. High prescribers were more likely to attribute responsibility to the previous physician who started the drug initially, to the age of patients "too old to change," to the comorbid conditions of the patients causing them suffering, and to the autonomy of the patient.12,13 Together, this constellation of factors expresses a hedonistic rather than a puritanical attitude toward benzodiazepines and indeed toward the theology of pharmacology.

However, the pervasive regulatory climate caused even the high end prescribers to have a sense of doing something immoral or illegal despite following the rules and acting within the standard of care. To manage this internal dissonance, the physicians justified their decisions in terms of humanism and compassion in accordance with hedonism. Those with lower volumes of benzodiazepine prescriptions were more comfortable with setting limits on patient demands, were more suspicious of patient motives, and were not afraid of making patients angry or running them off—approaches more consonant with puritanism.

These observations are not of merely academic interest when one realizes that in 1989, New York State instituted a triplicate prescription program for benzodiazepines, which most experts agree led to decreased use of the target drugs but increased use of older, more problematic medications such as barbiturates for the same eternal sedative-hypnotic indications.14 Note that both government qualms about abuse and diversion and clinician fears regarding punishment (legal action) of prescribers stand squarely in the line of puritanism.

Finding a balance
What is important to realize is that each time we write a prescription for alprazolam(Drug information on alprazolam) (Xanax) for a young woman with panic disorder or refuse to give an anxious elderly man diazepam(Drug information on diazepam) (Valium), our choices may not be nearly as grounded in dispassionate research as we might think. Being aware of one's personal beliefs regarding benzodiazepines and the social and philosophical forces acting on the fulcrum of prescribing can help all of us find a balanced position in accordance with the 1990 task force report on benzodiazepines of the American Psychiatric Association (APA).15 Benzodiazepines, the APA said (and most good clinicians know), are not so much drugs of abuse as drugs that can be abused. As I tell my residents, in the end it is still the doctor who controls the prescription and so we should err on the side of succor whenever reasonable and resume the reins if the pleasure so overwhelms the patient that it causes pain.

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Corey Yilmaz | September 04, 2011 8:09 PM EDT

1- no SSRI for Panic and GAD are a major problem- I think less than 50% of panic patients are on an SSRI--we have great generics for anxiety now- CITALOPRAM is my fvorite due to SE profile

2- for insomnia and anxety KLONOPIN- most patients with anxiety have INSOMNIA anyway so this has t b the #1 to try first

3- PMDs seem to me to be the IRRESPONSIBLE XANAX prescriers though were at fault too--I always give a limited #10 Klonopin or Valium to switch over- patietns realize that XANAX was a AMISTAKE by the prescriber (in most circumstances)

4- Ativan for elderly if you ahve to give a benzo due to it being short acting but not too sedating

by Chevies Newman | August 16, 2011 11:19 PM EDT

The concept of tonic vs phasic control of symptoms makes the most sense. Short acting Benzos in those having panic attacks, but who also haven't slept well in 3 years, is likely going to have people developing a dep affection for Xanax every 6 hours.

Treating insomnia with clonazepam and initiating an ssri may very well limit the daytime need for the short acting Meds during the day.

Well written article, very thoughtful. Thank you

by Vera Muensch | July 16, 2011 6:18 PM EDT

wonderfully stated!
thanks.
Vera Muensch, MD

by Mark Pichler | July 15, 2011 12:32 PM EDT

I'd like to thank Dr Geppert for this excellent review. However, I feel that the old saying of 'drugs serve as they destroy' should have been emphasized, especially when treating pts with a hx of addiction. Once addicted via chronic long term use, their clinical symptoms worsen, and the clinician is left wondering if their original anxiety disorder has worsened or it's secondary to BNZ dependency. In my experience, I've found that the cause is usually the later....

by James Patrick Murphy APRN, BC | July 14, 2011 4:52 PM EDT

Does not one have the obligation to the patient that he/she treats to use the most appropriate medication, in the proper vehicle, at the proper dose and frequency, and for the period necessary to treat the condition?? If you use this as a "litmus test" with Benzodiazepines, there will be those for whom you will, and will not, precribe them. It is that complex, and that simple.

Article Comment Pages: 1 2 3 Next






References
1. Uhlenhuth EH. Dispelling myths about benzodiazepines. J Clin Psychopharmacol. 1999;19(suppl 2):1S.
2. Uhlenhuth EH, Balter MB, Ban TA, Yang K. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications, IV: therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. J Clin Psychopharmacol. 1999;19(suppl 2): 23S-29S.
3. Uhlenhuth EH, Balter MB, Ban TA, Yang K. Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997. Eur Neuropsychopharmacol. 1999;9(suppl 6):S393-S398.
4. Uhlenhuth EH, DeWit H, Balter MB, et al. Risks and benefits of long-term benzodiazepine use. J Clin Psychopharmacol. 1988;8:161-167.
5. Rosenbaum JF. Attitudes toward benzodiazepines over the years. J Clin Psychiatry. 2005;66(suppl 2):4-8.
6. Klerman GL. Psychotropic hedonism vs pharmacological Calvinism. Hastings Cent Rep. 1972;2:1-3.
7. Kramer PD. Listening to Prozac. New York: Penguin Books; 1993.
8. Honderich T, ed. Oxford Companion to Philosophy. Oxford, England: Oxford University Press; 1995.
9. Richardson A, ed. A Dictionary of Christian Theology. Philadephia: Westminster Press; 1969.
10. Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Eur Neuropsychopharmacol. 1999;9(suppl 6):S399-S405.
11. Kramer M. Hypnotic medication in the treatment of chronic insomnia: non nocere! Doesn't anyone care? Sleep Med Rev. 2000;4:529-541.
12. Dybwad TB, Kjolsrod L, Eskerud J, Laerum E. Why are some doctors high-prescribers of benzodiazepines and minor opiates? A qualitative study of GPs in Norway. Fam Pract. 1997;14:361-368.
13. Bjorner T, Laerum E. Factors associated with high prescribing of benzodiazepines and minor opiates. A survey among general practitioners in Norway. Scand J Prim Health Care. 2003;21:115-120.
14. Schwartz HI. An empirical review of the impact of triplicate prescription of benzodiazepines. Hosp Community Psychiatry. 1992;43:382-385.
15. Salzman C. The APA Task Force report on benzodiazepine dependence, toxicity, and abuse. Am J Psychiatry. 1991;148:151-152.


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • The Moral Struggles of Practicing Psychiatrists
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Grief and Depression: The Sages Knew the Difference
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • The Role of Biological Tests in Psychiatric Diagnosis
  • You Are—And Your Mood Is—What You Eat
  • Experts Discuss Changes, Updates in DSM-5
  • The Paradox of Choice: When More Medications Mean Less Treatment
  • Will Your Clinical Records Support You in Court?
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Grief and Depression: The Sages Knew the Difference
  • Psychiatry and the Myth of “Medicalization”
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • NIMH vs DSM 5: No One Wins, Patients Lose
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • The Paradox of Choice: When More Medications Mean Less Treatment
  • Experts Discuss Changes, Updates in DSM-5
  • New Insight Into the Neurobiology of Depression
  • Tie One On for Patients
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
SearchMedica SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Display
Evidence on Display
Guidelines on Display
Patient Education on Display
Clinical Trials on Display
Practical Articles on Display
Research and Reviews on Display
All "Display" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy